Article
OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.
The pharmacogenomics journal - 1 Jun 2020
Ho Kwo Wei David, Wallace Margaret R, Staud Roland, Fillingim Roger B
Abstract excerpt
Genetic polymorphisms have been shown to affect opioid requirement for pain relief. However, true genetic effect is often difficult to assess due to underlying pain conditions and placebo effects. The goal of this study was to understand how common polymorphisms affect opioid effects while controlling for these factors. A randomized, double-blind, placebo-controlled study was implemented to assess how opioid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
